|
New York, NY, November 13, 2009,T12-NEWS reports that Revenue for Ariad Pharmaceuaticals (NASDAQ:ARIA) for its trailing twelve months (TTM) ended September 30, 2009 was $8,750,000, a 43.84% increase o ... read full story |
|
| Website Address: |
www.ariad.com |
| Industry: |
Bio-Pharma & Therapeutics
|
|